The British journal of dermatology
-
Clinical Trial Controlled Clinical Trial
A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectiveness.
A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.